1. Pintér A, Cseh D, Sárközi A, Illigens B, Siepmann T. Autonomic dysregulation in multiple
sclerosis. International Journal of Molecular Sciences. 2015; 16(8):16920-52.16920-16952
2. Bevan S, Steadman K. Multiple Sclerosis & Employment in Europe.2015
3. Etemadifar M, Sajjadi S, Nasr Z, Firoozeei TS, Abtahi SH, Akbari M, Fereidan-Esfahani
M. Epidemiology of multiple sclerosis in Iran: a systematic review. European neurology.
2013; 70(5-6):356-63.
4. Nortvedt M, Riise T, Frugaård J, Mohn J, Bakke A, Skår A, et al. Prevalence of
bladder, bowel and sexual problems among multiple sclerosis patients two to five years
after diagnosis. Multiple Sclerosis Journal. 2007; 13(1):106-12.
5. Sammarco Anne G, Orasanu Bogdan, Mahajan Sangeeta T. The Bladder in MS: A Review.
Neurol Neurophysiol, 20145:3
6. Tracey James M., Stoffel John T. Secondary and tertiary treatments for multiple
sclerosis patients with urinary symptoms. Investig Clin Urol 2016, 57:377-383.
7. Khalaf Kristin M., Coyne Karin S., Globe Denise R., Malone Daniel C., Armstrong
Edward P., Vaishali Patel,1 and Jack Burks.The Impact of Lower Urinary Tract Symptoms
on Health-Related Quality of Life Among Patients With Multiple Sclerosis. Neurourology
and Urodynamics 2016; 35:48–54
8. Betts CD, D’Mellow MT, Fowler CJ, Urinary symptoms and the neurological features
of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry1993; 56:
245–250.
9. Massot C, Khenioui H, Agnani O, Guyot M-A, Hautecoeur P, Donze C. Stress urinary
incontinence in women with multiple sclerosis. International neurourology journal
2016; 20(3):224.
10. Araki, I., Matsui, M., Ozawa, K., Nishimura, M., Kuno, S. and Saida, T, Relationship
between urinary symptoms and disease-related parameters in multiple sclerosis. J Neurol2002,
249: 1010
11. Kalsi V, Fowler CJ. Therapy Insight: bladder dysfunction associated with multiple
sclerosis. Nat Clin Pract Urol2005; 2(10): 492-501
12. Mahajan S. T., Patel P. B. Marrie R. A. Under Treatment of Overactive Bladder
Symptoms in Patients With Multiple Sclerosis: An Ancillary Analysis of the NARCOMS
Patient Registry ,The Journal of Urology2010; 183:1432-1437
13. Cox L, Cameron AP, Wittman D, Papin JE, Mao-Draayer Y. Analysis of urinary symptoms
and urodynamic findings in multiple sclerosis patients by gender and disease subtype.
J Neurol Neurobiol. 2015;1(2):1-5.
14. Wang T, Huang W, Zhang Y. Clinical Characteristics and Urodynamic Analysis of
Urinary Dysfunction in Multiple Sclerosis. Chin Med J 2016; 129:645-50
15. Saman-Nezhad Bahareh, Rezaee Tannaz, Bostani Arash, Najafi Farid. Aghaei Abbas.
Epidemiological Characteristics of Patients with Multiple Sclerosis in Kermanshah,
Iran in 2012. J Mazand Univ Med Sci2013; 23(104): 97-101 (Persian)
16. Ebers GC. Environmental factors and multiple sclerosis. Lancet Neurol 2008 ;7(3):268-77
17. Hojjati SMM, Zarghami A, Yousefzad T, Hojjati SA, Baes M., Epidemiological Features
of 263 Patients with Multiple Sclerosis Residing in Babol, Iran. J Babol Univ Med
Sci 2016;18(1):52-6. (Persian)
18. Hennessey A, Robertson N, Swingler R, Compston D. Urinary, faecal and sexual dysfunction
in patients with multiple sclerosis. Journal of neurology. 1999; 246(11):1027-32.
19. Sand PK, Sand RI. The diagnosis and management of lower urinary tract symptoms
in multiple sclerosis patients. Disease-a-month: DM. 2013; 59(7):261-8.
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic
criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol
2011; 69:292‑302
20.Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic
criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol
2011;69:292‑302
21. AbramsP,CardozoL,FallM,etal.The standardization of terminology of lower urinary
tract function:Report from the Standardisation Sub-committee of the International
Continence Society. Neurourol Urodynam 2002; 21:167–78.
22. Coyne KS, Sexton CC, Kopp Z, Chapple CR, Kaplan SA, Aiyer LP, Symonds T. Assessing
patients’ descriptions of lower urinary tract symptoms (LUTS) and perspectives on
treatment outcomes: results of qualitative research. International journal of clinical
practice. 2010 Aug 1; 64(9):1260-78.
23. Panahi Ali, Bidaki Reza, Mehraban Darab, Rezahosseini Omid. Validity and Reliability
of Persian Version of International Prostate Symptom Score. GMJ 2013; 2(1):18-21
24. Khalaf KM, Coyne KS, Globe DR, Armstrong EP, Malone DC, Burks J. Lower urinary
tract symptom prevalence and management among patients with multiple sclerosis. International
journal of MS care. 2015; 17(1):14-25.
25. Onal, B., Siva, A., Buldu, I., Demirkesen, O., & Cetinel, B. Voiding dysfunction
due to multiple sclerosis: a large scale retrospective analysis. International braz
j urol 2009, 35(3), 326-333.
26. Nakipoglu G, Kaya A, Orhan G, Tezen O, Tunc H, Ozgirgin N, et al. Urinary dysfunction
in multiple sclerosis. Journal of Clinical Neuroscience. 2009; 16(10):1321-4.
27. Tubaro A, Puccini F, De Nunzio C, Digesu G, Elneil S, Gobbi C, et al. The treatment
of lower urinary tract symptoms in patients with multiple sclerosis: a systematic
review.Current urology reports. 2012; 13(5):335-42.
28. Aharony, S. M., Lam, O., & Corcos, J. Evaluation of lower urinary tract symptoms
in multiple sclerosis patients: Review of the literature and current guidelines. Canadian
Urological Association Journal, 2017; 11(1-2), 61.
29. Gündoğdu AA, Kotan D, Atik YT, Sayan S, Sağlam HS. Lower Urinary Tract Dysfunction
in Multiple Sclerosis Patients.Sakarya Med J, 2016, 6(4):190-195
30. Goldstein I, Siroky M, Sax D, et al. Neurourologic abnormalities in multiple sclerosis.
J Urol 1982;128:541–5
31. Wheeler JS, Siroky MB, Pavlakis AJ, et al. The changing urologic pattern of multiple
sclerosis . J Urol 1983; 130:1123–5
32. Litwiller SE1, Frohman EM, Zimmern PE. Multiple sclerosis and the urologist. J
Urol. 1999 Mar;161(3):743-57
33. Gasquet I, Tcherny-Lessenot S, Gaudebout P, Bosio Le Goux B, Klein P, Haab F.
Influence of the severity of stress urinary incontinence on quality of life, health
care seeking, and treatment: a national cross-sectional survey. Eur Urol 2006; 50:818-25.
34. Dillon BF, Seideman CA. Lee D, Green berg B, Frohman Em, . A surprisingly low
prevalence of demonstra stress urinary in continence and pelvice organ prolapsein
women with multiple sclerosis followed at a teriary nerogenic bladder clinic2013;
J Urol
35.Yamaguchi, O., Aikawa, K., Shishido, K., & Nomiya, M. Place of overactive bladder
in male lower urinary tract symptoms. World journal of urology 2009, 27(6), 723.
36. Kaplan SA, Roehrborn CG, Chapple CR, Rosen RC, Irwin DE, Kopp Z, Aiyer LP, Mollon
P. Implications of recent epidemiology studies for the clinical management of lower
urinary tract symptoms. BJU international. 2009 ; 103:48-57.
37. Tracey James M., Stoffel John T. Secondary and tertiary treatments for multiple
sclerosis patients with urinary symptoms. Investig Clin Urol 2016; 57:377-383.
38. Pintér Alexandra, Cseh Domonkos, Sárközi Adrienn, Illigens Ben M., Siepmann Timo,.Autonomic
Dysregulation in Multiple SclerosisInt. J. Mol. Sci. 2015; 16, 16920-16952
39. Goldstein I, Siroky MB, Sax DS, Krane RJ. Neurourologic abnormalities in multiple
sclerosis. The Journal of urology1982;128 (3):541-5.
40. Cox L, Cameron AP, Wittman D, Papin JE, Mao-Draayer Y. Analysis of urinary symptoms
and urodynamic findings in multiple sclerosis patients by gender and disease subtype.
J Neurol Neurobiol2015; 1(2):1-5.